Augment Therapy Secures $1M Investment to Revolutionize Immersive Digital Health Solutions

Augment Therapy is excited to announce that it has successfully raised $1,000,000 in new funding, a significant milestone that reinforces the company’s mission to transform digital health experiences from hospital to home. As an award-winning digital health company, Augment Therapy® has already made waves with its innovative applications, ARWell and ARWell PRO, which utilize the company’s proprietary MOCAST® technology. This funding will accelerate the ongoing development of these immersive exercise platforms, enabling further enhancements in full-body skeletal tracking and augmented reality-based games that empower users of all ages and abilities. The infusion of capital is poised to not only expand the reach of ARWell products, which cater to general wellness without prescription requirements, but also to strengthen ARWell PRO, a solution designed for healthcare providers and their patients. Healthcare professionals will continue to benefit from robust user data, in-app analytics, and comprehensive monitoring capabilities, all of which simplify patient engagement and progress tracking. Founded in 2018 by CEO Lindsay Watson, a seasoned physical therapist with over 20 years of experience, and CTO Steve Blake, a veteran in medical and tech-education software, the company is headquartered in Cleveland, Ohio. Augment Therapy’s impressive track record is highlighted by numerous accolades, including the Unity for Humanity award in 2022 and recognition as a finalist for AWE’s Auggie Awards and the Digital Health Awards in 2023. This funding will further empower the company to innovate at the intersection of healthcare and technology, enhancing both patient outcomes and user engagement while paving new avenues in digital wellness.